Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Kiyoaki Uryu"'
Autor:
Ken Kodama, Toru Momozane, Kaichi Shigetsu, Hiroshi Takehara, Takamasa Toyofuku, Kinji Nishiyama, Genju Koh, Kiyoaki Uryu
Publikováno v:
Clinical Case Reports, Vol 12, Iss 1, Pp n/a-n/a (2024)
Key Clinical Message Under the current progression of molecular targeting or immune therapy, early detection and radiation therapy of iliopsoas metastasis will not only improve performance status but also enable the continuation of effective systemic
Externí odkaz:
https://doaj.org/article/926b34ac5fd242d386e0230aa2cb324c
Autor:
Akihiro Yoshimura, Takayuki Takeda, Nobutaka Kataoka, Keiko Tanimura, Mototaka Fukui, Yusuke Chihara, Shota Takei, Hayato Kawachi, Kentaro Nakanishi, Yuta Yamanaka, Nobuyo Tamiya, Ryoichi Honda, Naoko Okura, Takahiro Yamada, Kiyoaki Uryu, Junji Murai, Shinsuke Shiotsu, Hiroshige Yoshioka, Tadaaki Yamada, Takayasu Kurata, Koichi Takayama
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionThe efficacy of second-line immune checkpoint inhibitor (ICI) therapy is limited in non-small cell lung cancer (NSCLC) patients with ≤ 49% PD-L1 expression. Although chemoimmunotherapy is a promising strategy, platinum-based chemotherap
Externí odkaz:
https://doaj.org/article/8d57729f3fdc4dbb893f9ca297d30e84
Autor:
Makoto, Hibino, Kiyoaki, Uryu, Takayuki, Takeda, Yusuke, Kunimatsu, Shinsuke, Shiotsu, Junji, Uchino, Soichi, Hirai, Tadaaki, Yamada, Asuka, Okada, Yoshikazu, Hasegawa, Osamu, Hiranuma, Yusuke, Chihara, Riko, Kamada, Shunichi, Tobe, Kazunari, Maeda, Shigeto, Horiuchi, Tetsuri, Kondo, Koichi, Takayama
Publikováno v:
Journal of Thoracic Oncology. 17:1002-1013
Patients with cancer have been prioritized for vaccination against severe acute respiratory syndrome coronavirus 2. Nevertheless, there are limited data regarding the safety, efficacy, and risk of developing immune-related adverse events (irAEs) asso
Autor:
Takumi Noda, Ryuji Kato, Yasuyuki Ozato, Yuka Kawai, Masato Yamamoto, Yuya Kagawa, Misa Azuma, Kojiro Yamamoto, Mika Kusanagi, Kiyoaki Uryu, Hiromasa Harada, Yoshio Ijiri, Tetsuya Hayashi, Kazuhiko Tanaka
Publikováno v:
Biopharmaceutics & Drug Disposition. 43:108-116
Acetaminophen (APAP)-induced liver injury (AILI) is the most common cause of acute liver failure. Although the mechanisms that trigger AILI are well known, it is less understood how to halt AILI progression and facilitate liver recovery. Therefore, i
Autor:
Yu Mizutani, Shinichiro Kawamoto, Michiko Takahashi, Hisayo Doi, Kumiko Wakida, Satoko Tabuchi, Masaaki Tanda, Akihiro Soga, Ruri Chijiki, Hidetomo Takakura, Koji Kawaguchi, Ako Higashime, Marika Watanabe, Hiroya Ichikawa, Sakuya Matsumoto, Rina Sakai, Hideaki Goto, Keiji Kurata, Seiji Kakiuchi, Yoshiharu Miyata, Kiyoaki Uryu, Yumiko Inui, Akihito Kitao, Kimikazu Yakushijin, Hiroshi Matsuoka, Hironobu Minami
Publikováno v:
Internal Medicine.
Autor:
Yu Mizutani, Shinichiro Kawamoto, Michiko Takahashi, Hisayo Doi, Kumiko Wakida, Satoko Tabuchi, Masaaki Tanda, Akihiro Soga, Ruri Chijiki, Hidetomo Takakura, Koji Kawaguchi, Ako Higashime, Marika Watanabe, Hiroya Ichikawa, Sakuya Matsumoto, Rina Sakai, Hideaki Goto, Keiji Kurata, Seiji Kakiuchi, Yoshiharu Miyata, Kiyoaki Uryu, Yumiko Inui, Akihito Kitao, Kimikazu Yakushijin, Hiroshi Matsuoka, Hironobu Minami
We aimed to assess the efficacy and safety of synbiotics, including live microorganisms and non-digestible food ingredients, in patients undergoing high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (auto-HSCT). Thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abd9ebe0aae328065a6d536962c55e19
https://doi.org/10.21203/rs.3.rs-2071083/v1
https://doi.org/10.21203/rs.3.rs-2071083/v1
Autor:
Takayuki Takeda, Tadaaki Yamada, Yusuke Kunimatsu, Keiko Tanimura, Kenji Morimoto, Shinsuke Shiotsu, Yusuke Chihara, Asuka Okada, Shigeto Horiuchi, Makoto Hibino, Kiyoaki Uryu, Ryoichi Honda, Yuta Yamanaka, Hiroshige Yoshioka, Takayasu Kurata, Koichi Takayama
Publikováno v:
Cancers
Volume 15
Issue 5
Pages: 1543
Volume 15
Issue 5
Pages: 1543
Chemoimmunotherapy improved overall survival (OS) and progression-free survival (PFS) in patients with extensive-stage small cell lung cancer (ES-SCLC) in two phase III trials. They set the age-stratified subgroup analyses at 65 years; however, over
Autor:
Rai Shimoyama, Yoshinori Imamura, Kiyoaki Uryu, Takahiro Mase, Yoshiaki Fujimura, Maki Hayashi, Megu Ohtaki, Keiko Otani, Nobuaki Shinozaki, Hironobu Minami
Publikováno v:
Annals of Oncology. 33:S484-S485
Autor:
Rai Shimoyama, Yoshinori Imamura, Kiyoaki Uryu, Takahiro Mase, Yoshiaki Fujimura, Maki Hayashi, Megu Ohtaki, Keiko Otani, Hironobu Minami, Nobuaki Shinozaki
Publikováno v:
Annals of Oncology. 33:S485-S486
Autor:
Makoto Hibino, Shigehiro Watanabe, Shunichi Tobe, Kazunari Maeda, Shigeto Horiuchi, Sho Nishiguchi, Akihiko Iwase, Kiyoaki Uryu, Shuzo Kobayashi, Tetsuri Kondo
Publikováno v:
Respiratory Investigation
Background There are many commercially available automated assays for assessing coronavirus disease 2019 (COVID-19) immune responses; however, owing to insufficient data, their validities remain unknown. Here, we examined antibody responses during ac